Associate Professor
Icahn School of Medicine at Mount Sinai /James J. Peters Veteran Affairs Medical Center, New York, United States
Dr. Qin is an associate professor at the Icahn School of Medicine at Mount Sinai & James J. Peters Veteran Affairs Medical Center, based in New York City. Dr. Qin received his M.D. degree from Fujian Medical University, China, in 1987, and his Ph.D. degree from Kanazawa University, Japan, in 2001. Dr. Qin is a recognized authority on studying neuromusculoskeletal disorders after spinal cord injury (SCI). Since 2007, Dr. Qin has evaluated mechanisms of bone loss after SCI and has developed pharmacological interventions to block bone loss or restore bone mass after SCI. More recently, Dr. Qin has developed a novel cutting-edge nanomedicine approach for drug-targeted delivery as more efficacious and safer method to provide neuroprotection and functional recovery in acute SCI. Dr. Qin recently also discovered a novel mechanism of muscle-bone crosstalk in maintaining homeostasis of the local musculoskeletal environment through osteocytes by the generation and release of microRNAs from extracellular microvesicle-exosomes. One of Dr. Qin’s recent studies has highlighted on the DoD CDMRP website for its significance and high impact in the field (https://cdmrp.health.mil/scirp/research_highlights/14qin_highlight). More recently, Dr. Qin’s preclinical work in bone disease following SCI was reported by Yahoo Finance, Bloomberg, Webull, BioSpace, Statmuse, Biopharmcatalyst, Cnyes Invest, etc.
Disclosure information not submitted.
Nanomedicine and Nanoscale Delivery IV
Wednesday, July 10, 2024
2:30 PM – 4:30 PM CET
